Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
February 27, 2023 at 08:53 am EST
Share
Farmacias Benavides, S.A.B. de C.V. reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported sales was MXN 4,390.01 million compared to MXN 3,772.92 million a year ago. Net loss was MXN 77.28 million compared to MXN 68.39 million a year ago. Basic loss per share from continuing operations was MXN 0.189018 compared to MXN 0.167286 a year ago.
For the full year, sales was MXN 16,229.64 million compared to MXN 14,743.06 million a year ago. Net income was MXN 47.96 million compared to MXN 9.71 million a year ago. Basic earnings per share from continuing operations was MXN 0.117314 compared to MXN 0.023752 a year ago.
Farmacias Benavides SAB de CV is a Mexico-based company primarily engaged in the pharmaceutical and chemical industry. The Company operates a network of over 700 drug stores located nationwide under the Farmacias Benavides name. Through its network of drug stores, it sells a variety prescription and over the counter (OTC) medicines, cosmetics, personal and baby care products and toiletries, as well as it also provides such related services as laboratory samples, home delivery, prescription laboratory, online pharmacy and photo processing services. As of December 31, 2011, the Company owned such subsidiaries as Servicios Operacionales Benavides SA de CV, Benavides de Reynosa SA de CV and Servicios Logisticos Benavides SA de CV, and Fasa Investment Limitada which was its majority shareholder with 85.25% of its interest.
FARMACIAS BENAVIDES, S.A.B. DE C.V. 
